Skip to search.
 TSX Down 0.42% TSX Ventures Down 1.40%

More On I.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

IntelliPharmaCeutics International Inc. (I.TO)

-Toronto
2.74 Down 0.18(6.16%) 3:52PM EDT
Prev Close:2.92
Open:2.92
Bid:2.73
Ask:2.78
1y Target Est:N/A
Beta:0.214872
Earnings Date:Oct 7 - Oct 11 (Est.)
Day's Range:2.70 - 2.92
52wk Range:1.78 - 4.20
Volume:32,956
Avg Vol (3m):13,395
Market Cap:79.36M
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Press Releases

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):29.88
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Intellipharmaceutics International Inc., a pharmaceutical company, engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs in Canada. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback